Watch our CMO, Byron Elton, cover the most important news and developments in the cancer industry
September 16, 2023 - The Financial Burden
September 16, 2023 - A Monumental Meeting at UCLA
September 13, 2023 - Fighting Cancer with Microsoft AI
September 11, 2023 - Early Onset Cancer
September 11, 2023 - Jimmy Buffett
August 13, 2023 - National Cancer Plan
August 9, 2023 - Onset Colon Cancer
August 3, 2023 - Paul Reubens
June 28, 2023 - Research Turning Point
May 26, 2023 - Mammograms
May 24, 2023 - mRNA Vaccine
Keep up with our progress by subscribing to our email newsletter!
This Reg A+ offering is made available through StartEngine Primary, LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. You should read the Selected Risks, the Offering Circular, and Sec Edgar Page before investing.